Clinical Trials Logo

Filter by:
NCT ID: NCT05683899 Completed - Length of Stay Clinical Trials

A Study of Emergency Department AI Prediction Impact

Start date: January 3, 2023
Phase:
Study type: Observational

The purpose of this study is to evaluate the impact of an AI admission prediction tool on the number of preventable hospital admissions, emergency department (ED) length of stay, when the predictions are displayed only to a dedicated ED triage team. Also, to evaluate user perceptions of the AI tool among the triage team users and medical officer of the day users. Additionally, to evaluate any impact of the AI tool on the number of interventions performed by the triage team, and to evaluate the impact of the tool on time-to-admission after an admission order is placed.

NCT ID: NCT05683535 Completed - Myopia, Progressive Clinical Trials

Adverse Events Related to Low Dose Atropine

AELDA
Start date: June 19, 2018
Phase:
Study type: Observational

Progressive myopia can lead to severe vision loss and is associated with retinal detachment, glaucoma, and other comorbidities. Several studies have shown that off-label, low-dose atropine eye drops slow the progression of myopia. Many eye care providers are now prescribing off-label atropine eye drops for their myopic patients, with the prescribed concentrations varying amongst providers. The purpose of this study is to determine if low-dose atropine eyedrops used daily, cause adverse effects to the eyes. Patients currently using 0.01%, 0.03%, or 0.05% atropine eye drops obtained from compounding pharmacies will be assessed for associated adverse effects.

NCT ID: NCT05683431 Completed - Bipolar Disorder Clinical Trials

Using Neuroplasticity-Based Computerized Training to Improve Emotion Regulation in Bipolar Disorder (BRAINS)

BRAINS
Start date: March 22, 2019
Phase: N/A
Study type: Interventional

The goal of this study is to evaluate the feasibility and potential benefit of a behavioral intervention designed to improve emotion regulation in individuals with bipolar disorder. The intervention consists of game-like exercises that involve the 'Cognitive Control of Emotion (CCE) - i.e. the ability to control the influence of emotional information on behavior. Deficits in the cognitive control of emotion are a central feature of Bipolar Disorder that contributes to emotion dysregulation, maladaptive mood episodes, and, ultimately, the overall chronicity and severity of illness. Neuroimaging studies of bipolar patients demonstrate neural abnormalities in brain systems involved in cognitive control and emotion processing. Furthermore, these abnormalities predict mood and behavior problems associated with cognitive control of emotion, such as emotion lability, disinhibited behavior, and extreme mood states. The aim of this study is to determine feasibility and examine whether a computer-based program of progressively difficult cognitive control emotion exercises will improve cognitive control of emotion skills and, thereby, result in better emotion regulation and daily functioning in young adults with bipolar disorder. To test the intervention, a single group of young adults (18-30 years old) with Bipolar I Disorder will complete behavioral assessments before and after 20 hours (4 weeks) of CCE training. In order to identify baseline deficits associated with bipolar disorder, a comparison group of healthy young adults will complete behavioral assessments at a single time-point (without CCE training).

NCT ID: NCT05683392 Completed - Type 1 Diabetes Clinical Trials

Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to assess safety of and explore glycemic outcomes with Control-IQ technology 2.0 in adults, children and preschoolers with type 1 diabetes.

NCT ID: NCT05683366 Completed - Clinical trials for SpO2 (Peripheral Oxygen Saturation) Measurement Validation

Philps FAST2022 picoSAT Pulse Oximetry Desaturation Study

Start date: December 13, 2022
Phase:
Study type: Observational

Validation study to compare the accuracy of non-invasive Philips SpO2 sensors in detecting blood oxygen levels compared to invasive methods requiring a blood draw and lab analysis.

NCT ID: NCT05683249 Completed - ADHD Clinical Trials

Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)

Start date: February 25, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

The goal of this clinical trial is to evaluate the efficacy and safety of NRCT-101SR compared to placebo in adult patients with ADHD aged 18 years and older.

NCT ID: NCT05682729 Completed - Clinical trials for Mathematics Abilities

Flexible Attention to Magnitudes and Early Math

FAM
Start date: December 5, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test the malleability of preschool-aged children's flexible attention to numerical and spatial magnitudes. The main questions it aims to answer are: Does a flexible attention to magnitudes intervention improve young children's math abilities in the area of flexible attention to magnitudes as well as executive functioning and number line estimation skills? Does this intervention improve young children's math abilities more than a traditional counting intervention? "Does the method of flexible attention to magnitudes intervention affect how much children improve in their math abilities? Participants will complete a pre-test and post-test in their math abilities and three intervention sessions with a trained experimenter. Each intervention session will involve reading researcher-created books with one-on-one with children for about 20 minutes. Children will be assigned to one of four intervention conditions: - Size to Number Intervention Condition - Size and Number Mixed Intervention Condition - Traditional Counting Intervention - Non-Numerical Control Intervention

NCT ID: NCT05682040 Completed - Clinical trials for Lower Extremity Deep Vein Thrombosis

Effect of Emergency Department Bedside Compression Ultrasonography on Door-to-Disposition Time in Patients Suspicious for Lower Extremity Deep Venous Thrombosis

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

Comparing the disposition time of point of care ultrasound (POCUS) versus formal lower extremity doppler in emergency department patients.

NCT ID: NCT05681715 Completed - Clinical trials for Generalized Myasthenia Gravis

A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)

Start date: April 17, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the ability of study participants with generalized Myasthenia Gravis (gMG) to successfully self-administer rozanolixizumab after training in the self-administration technique using the syringe driver and manual push methods.

NCT ID: NCT05681182 Completed - Clinical trials for Post Operative Atrial Fibrillation

Prevention of Post-OP AFib Using Combination of CardiaMend and Amiodarone

CAMP POAF
Start date: January 20, 2023
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the combination of CardiaMend, with the addition of amiodarone in the prevention of postoperative atrial fibrillation (POAF) in patients undergoing isolated cardiac arterial bypass grafting (CABG) or valve surgery.